Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging

Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is an emerging imaging modality with greater sensitivity and specificity over conventional imaging for prostate cancer (PCa) staging. Using data from two prospective trials (NCT03368547 and NCT04050...

Full description

Bibliographic Details
Main Authors: Armstrong, W. (Author), Calais, J. (Author), Chu, C. (Author), Czernin, J. (Author), Deng, J. (Author), Elashoff, D. (Author), Feng, F. (Author), Gafita, A. (Author), Grogan, T.R (Author), Juarez, J. (Author), Kishan, A.U (Author), Kupelian, P.A (Author), Lok, V. (Author), Ma, T.M (Author), Muralidhar, V. (Author), Nguyen, K. (Author), Nickols, N.G (Author), Parikh, N.R (Author), Reiter, R.E (Author), Rettig, M.B (Author), Savjani, R. (Author), Shabsovich, D. (Author), Sonni, I. (Author), Steinberg, M.L (Author), Thin, P. (Author), Yang, D.D (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Conventional imaging
Gleason grade
Nomogram
Overall upstaging
Percent positive core
Positron emission tomography/computed tomography
Prostate cancer
Prostate-specific membrane antigen
Staging
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items